WHO issued a medical product alert on four cough syrups made by an Indian company.

WHO issued a medical product alert on four cough syrups made by an Indian company.

World Health Organization (WHO) issued a medical product alert on four cough and cold syrups made by an Indian company. The WHO has said that the usage of these four cough syrups have potentially caused acute kidney injuries and 66 deaths among children in Gambia. The WHO on wednesday flagged four contaminated and substandard cough syrups made by Maiden Pharmaceuticals Limited in Haryana; which have been largely used for pediatric use, are believed to contain chemicals that are toxic and potentially fatal.

The four cough and cold syrups are Promethazine Oral Solution; Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup. In a release, the WHO has said that the Indian company has not yet provided guarantees on the safety and quality of these products. It also cautioned that the contaminated medications may have been distributed outside of the West African country, with global exposure possible.

The laboratory analysis of samples of each of the four products confirms they contain unacceptable amounts of diethylene glycol.

The laboratory analysis of samples of each of the four products confirms they contain unacceptable amounts of diethylene glycol; and ethylene glycol, both toxic to humans when consumed and can prove fatal. After the WHO’s alert, the Central Drugs Standard Control Organisation (CDSCO) has taken this matter under urgent investigation, sources told news agency ANI. Urgent investigation in the matter has been already taken up by CDSCO with the State Regulatory Authorities immediately after receiving communication from WHO based on the available information,” they said.

deccannews

Leave a Reply

Your email address will not be published. Required fields are marked *